Autoantibodies against cardiac troponin I are responsible for dilated cardiomyopathy in PD-1-deficient mice
The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Abstract
We recently reported that mice deficient in the programmed cell death-1 (PD-1) immunoinhibitory coreceptor develop autoimmune dilated cardiomyopathy (DCM), with production of high-titer autoantibodies against a heart-specific, 30-kDa protein. In this study, we purified the 30-kDa protein from heart extract and identified it as cardiac troponin I (cTnI), encoded by a gene in which mutations can cause familial hypertrophic cardiomyopathy (HCM). Administration of monoclonal antibodies to cTnI induced dilatation and dysfunction of hearts in wild-type mice. Monoclonal antibodies to cTnI stained the surface of cardiomyocytes and augmented the voltage-dependent L-type Ca2+ current of normal cardiomyocytes. These findings suggest that antibodies to cTnI induce heart dysfunction and dilatation by chronic stimulation of Ca2+ influx in cardiomyocytes.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“the cardiotoxicity of anti-cTnI autoantibodies has been reported in studies using BALB/c mice lacking PD-1 expression”
From Autoimmune Myocarditis, Old Dogs and New Tricks. (2024) · cites this paper as [97]
In the citing paper
“PD-1-deficient BALB/c mice spontaneously developed autoimmune DCM mediated by anti-cTnI antibodies, and the pathology was transferable when wild-type mice were treated with these autoantibodies”
From Autoimmune Myocarditis, Old Dogs and New Tricks. (2024) · cites this paper as [97]
In the citing paper
“suggesting a potential mechanism of ICI myocarditis.”
From Autoimmune Myocarditis, Old Dogs and New Tricks. (2024) · cites this paper as [97]
In the citing paper
“the cardiotoxicity of anti-cTnI antibodies has been reported in PD-1 -/- BALB/c mice”
From Autoimmune Myocarditis, Old Dogs and New Tricks. (2024) · cites this paper as [97]
In the citing paper
“However, these autoantibodies are generally not disease-specific and may not consistently induce the disease phenotype in murine models, indicating their limitations as diagnostic and therapeutic targets. 57,92,97,191”
From Autoimmune Myocarditis, Old Dogs and New Tricks. (2024) · cites this paper as [97]
Citations
Cites
Hamill, O. P., Marty, A., Neher, E., Sakmann, B., & Sigworth, F. J. (1981) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/bf00656997 · Cited by 18,436
A Calcineurin-Dependent Transcriptional Pathway for Cardiac Hypertrophy
Molkentin, J. D., Lu, J.-R., Antos, C. L., Markham, B., Richardson, J., Robbins, J., Grant, S. R., & Olson, E. N. (1998) · Cell · doi:10.1016/s0092-8674(00)81573-1 · Cited by 2,566
Autoimmune Dilated Cardiomyopathy in PD-1 Receptor-Deficient Mice
Nishimura, H., Okazaki, T., Tanaka, Y., Nakatani, K., Hara, M., Matsumori, A., Sasayama, S., Mizoguchi, A., Hiai, H., Minato, N., et al. (2001) · Science · doi:10.1126/science.291.5502.319 · Cited by 1,868
Self-citationThe Genetic Basis for Cardiomyopathy
Seidman, J. G., & Seidman, C. (2001) · Cell · doi:10.1016/s0092-8674(01)00242-2 · Cited by 1,046
Calcium tolerant ventricular myocytes prepared by preincubation in a ?KB medium?
Isenberg, G., & Klockner, U. (1982) · Pfl�gers Archiv European Journal of Physiology · doi:10.1007/bf00584963 · Cited by 898
Mutations in Sarcomere Protein Genes as a Cause of Dilated Cardiomyopathy
Kamisago, M., Sharma, S. D., DePalma, S. R., Solomon, S., Sharma, P., McDonough, B., Smoot, L., Mullen, M. P., Woolf, P. K., Wigle, E. D., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200012073432304 · Cited by 720
Mutations in the cardiac troponin I gene associated with hypertrophic cardiomyopathy
Kimura, A., Harada, H., Park, J.-E., Nishi, H., Satoh, M., Takahashi, M., Hiroi, S., Sasaoka, T., Ohbuchi, N., Nakamura, T., et al. (1997) · Nature Genetics · doi:10.1038/ng0897-379 · Cited by 577
Cardiac myosin induces myocarditis in genetically predisposed mice.
Neu, N., Rose, N. R., Beisel, K. W., Herskowitz, A., Gurri-Glass, G., & Craig, S. W. (1987) · The Journal of Immunology · doi:10.4049/jimmunol.139.11.3630 · Cited by 526
Cardiac defects and altered ryanodine receptor function in mice lacking FKBP12
Shou, W., Aghdasi, B., Armstrong, D. L., Guo, Q., Bao, S., Charng, M.-J., Mathews, L. M., Schneider, M. D., Hamilton, S. L., & Matzuk, M. M. (1998) · Nature · doi:10.1038/35146 · Cited by 431
Cited by
Items 401–500 of 688
Genome-wide association study of cardiac troponin I in the general population
Moksnes, M. R., Røsjø, H. R., Richmond, A., Lyngbakken, M. N., Graham, S. E., Hansen, A. F., Wolford, B. N., Taliun, S. A. G., LeFaive, J., Rasheed, H., et al. (2021) · Human Molecular Genetics · doi:10.1093/hmg/ddab124 · Cited by 16
Immune-Checkpoint Inhibitor-Related Myocarditis: Where We Are and Where We Will Go
Vergara, A., Felice, M. D., Cesaro, A., Gragnano, F., Pariggiano, I., Golia, E., Pasquale, A. D., Blasi, E., Fimiani, F., Monda, E., et al. (2023) · Angiology · doi:10.1177/00033197231201929 · Cited by 17
Tan, S., Chang, Q., Zeng, H., Wei, Q., Huang, Q. M., Pu, X., Li, W., Li, Y., & Tian, P. (2024) · Cardiovascular Toxicology · doi:10.1007/s12012-024-09918-6 · Cited by 17
Myocardial Inflammation and Sudden Death in the Inherited Cardiomyopathies
McKenna, W. J., & Caforio, A. L. P. (2022) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2022.01.004 · Cited by 19
Sugita, S., Horie, S., Yamada, Y., Keino, H., Usui, Y., Takeuchi, M., & Mochizuki, M. (2010) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.09-4460 · Cited by 16
Chen, J., Larsson, L., Haugen, E., Fedorkova, O. M., Angwald, E., Waagstein, F., & Fu, M. L. X. (2006) · European Journal of Heart Failure · doi:10.1016/j.ejheart.2005.10.019 · Cited by 16
Wu, A. H. B. (2006) · Circulation · doi:10.1161/circulationaha.106.652123 · Cited by 16
Gelsolin and Cardiac Myocyte Apoptosis
Nishio, R., & Matsumori, A. (2009) · Circulation Research · doi:10.1161/circresaha.109.196329 · Cited by 16
Self-citationLi, S., Geng, Z., Hong, S., Zhang, J., Yang, Y., Qin, W. D., Zhang, X., Zhuang, X., Huo, R., Han, S., et al. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1656063 · Cited by 24
Self-citationNavigating Cardiotoxicity in Immune Checkpoint Inhibitors: From Diagnosis to Long-Term Management
Nardin, S., Ruffilli, B., Costantini, P., Mollace, R., Taglialatela, I., Pagnesi, M., Chiarito, M., Soldato, D., Cao, D., Conte, B., et al. (2025) · Journal of Cardiovascular Development and Disease · doi:10.3390/jcdd12070270 · Cited by 17
Kumar, S., Sarthi, P., Mani, I., Ashraf, M. U., Kang, M.-H., Kumar, V., & Bae, Y. (2021) · Cells · doi:10.3390/cells10092250 · Cited by 20
Assessing the risk of cardiovascular events in patients receiving immune checkpoint inhibitors
Torrente, M., Clemente, M. B., Franco, F., Garitaonaindía, Y., Calvo, V., Collazo-Lorduy, A., Gutiérrez, L., Sánchez, J. C., del Alba, A. G., Hernández, R., et al. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.1062858 · Cited by 16
Biomarkers After Heart Transplantation: Nongenomic
Dengler, T. J., Gleissner, C. A., Klingenberg, R., Sack, F., Schnabel, P. A., & Katus, H. A. (2007) · Heart Failure Clinics · doi:10.1016/j.hfc.2007.02.010 · Cited by 15
CD8 T‐cell regulation by T regulatory cells and the programmed cell death protein 1 pathway
Penaloza‐MacMaster, P. (2017) · Immunology · doi:10.1111/imm.12739 · Cited by 15
Czaja, A. J. (2019) · Autoimmunity · doi:10.1080/08916934.2019.1641200 · Cited by 15
Immunotherapy-associated cardiovascular toxicities: insights from preclinical and clinical studies
Kong, Y., Wang, X., & Qie, R. (2024) · Frontiers in Oncology · doi:10.3389/fonc.2024.1347140 · Cited by 14
Immune checkpoint inhibitor toxicity: A new indication for therapeutic plasma exchange?
Compton, F., He, L., Sarode, R., Wodajo, A., Usmani, A., Burner, J. D., Berlacher, M. D., & Simone, N. D. (2021) · Journal of Clinical Apheresis · doi:10.1002/jca.21890 · Cited by 14
Overcoming the cardiac toxicities of cancer therapy immune checkpoint inhibitors
Irabor, O. C., Nelson, N. G., Shah, Y., Niazi, M. Z., Poiset, S., Storozynsky, E., Singla, D. K., Hooper, D. C., & Lu, B. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.940127 · Cited by 16
A protective role for programmed death 1 in progression of murine adriamycin nephropathy
Qin, X. H., Lee, V. W., Wang, Y. P., Zheng, G., Wang, Y., Alexander, S. I., & Harris, D. C. H. (2006) · Kidney International · doi:10.1038/sj.ki.5000345 · Cited by 14
Briet, C., Bourdenet, G., Rogner, U. C., Bécourt, C., Tardivel, I., Drouot, L., Arnoult, C., do-Rego, J.-C., Prevot, N., Massaad, C., et al. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00287 · Cited by 14
Yamamoto, Y., Kakizaki, M., Shimizu, T., Carreras, J., Chiba, T., Chamoto, K., Kagawa, T., Aoki, T., Nakamura, N., Ando, K., et al. (2020) · International Immunology · doi:10.1093/intimm/dxaa018 · Cited by 16
How can we manage the cardiac toxicity of immune checkpoint inhibitors?
Poto, R., Marone, G., Pirozzi, F., Galdiero, M. R., Cuomo, A., Formisano, L., Bianco, R., Corte, C. M. D., Morgillo, F., Napolitano, S., et al. (2021) · Expert Opinion on Drug Safety · doi:10.1080/14740338.2021.1906860 · Cited by 14
Detection of antibodies in cardiac autoimmunity
Wehlou, C., & Delanghe, J. (2009) · Clinica Chimica Acta · doi:10.1016/j.cca.2009.08.002 · Cited by 17
Talele, N. P., Kumra, H., Gomes-Santos, I. L., Ho, W. W., Andersson, P., Siwicki, M. R., Huang, P., Duda, D. G., Pittet, M. J., Fukumura, D., et al. (2025) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2024-011404 · Cited by 13
Synergistic Association of Serum Albumin and Globulin with Coronary Heart Disease
Wang, M., Liu, J., Ma, C., Wang, W., Liu, X., Li, Y., Sun, J., Liu, J., Qi, Y., Lv, Q., et al. (2012) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.10322 · Cited by 14
Zheng, Z., Yu, Y., Potla, R., Wu, Y., & Wu, H. (2017) · Immunology · doi:10.1111/imm.12837 · Cited by 13
Savukoski, T., Jacobino, J., Laitinen, P. H., Lindahl, B., Venge, P., Ristiniemi, N., Wittfooth, S., & Pettersson, K. S. I. (2014) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2013-1044 · Cited by 13
Program death-1 regulates peripheral T cell tolerance via an anergy-independent mechanism
Qiao, G., Yang, L., Li, Z., Ying, H., Hassen, Y., Yin, F., & Zhang, J. (2012) · Clinical Immunology · doi:10.1016/j.clim.2012.02.006 · Cited by 13
Moriguchi, T., Koizumi, K., Matsuda, K., Harii, N., Goto, J., Harada, D., Sugawara, H., Hoshiai, M., Kise, H., & Baba, A. (2017) · Journal of Artificial Organs · doi:10.1007/s10047-017-0956-7 · Cited by 15
Diamantopoulos, P. T., Tsatsou, K., Benopoulou, Ο., Bonou, M. S., Anastasopoulou, A. N., Mastrogianni, E., & Gogas, H. J. (2020) · Melanoma Research · doi:10.1097/cmr.0000000000000681 · Cited by 13
Nivolumab-induced myocardial necrosis in a patient with lung cancer: A case report
Sakai, T., Yahagi, K., Hoshino, T., Yokota, T., Tanabe, K., Mori, M., & Ikeda, S. (2019) · Respiratory Medicine Case Reports · doi:10.1016/j.rmcr.2019.100839 · Cited by 14
Mechanisms and models of peripheral CD4 T cell self-tolerance
Colin, C. A. (2004) · Frontiers in bioscience · doi:10.2741/1450 · Cited by 13
Terawaki, S., Tanaka, Y., Nagakura, T., Hayashi, T., Shibayama, S., Muroi, K., Okazaki, T., Mikami, B., Garboczi, D. N., Honjo, T., et al. (2007) · International Immunology · doi:10.1093/intimm/dxm059 · Cited by 13
Self-citationTroponin Autoantibodies: From Assay Interferent to Mediator of Cardiotoxicity
Park, J. Y., & Jaffe, A. S. (2016) · Clinical Chemistry · doi:10.1373/clinchem.2016.268920 · Cited by 13
Preclinical mouse models of immune checkpoint inhibitor-associated myocarditis
Fankhauser, R. G., Johnson, D. B., Moslehi, J. J., & Balko, J. M. (2025) · Nature Cardiovascular Research · doi:10.1038/s44161-025-00640-2 · Cited by 14
Zhang, C., Chen, Z., Mo, C., Gao, D., Zhu, Y., Qin, S., & Zuo, Z. (2021) · PubMed · Cited by 13
Immune Checkpoint Inhibitors Related to Cardiotoxicity
Chen, R., Zhou, M., & Zhu, F. (2022) · Journal of Cardiovascular Development and Disease · doi:10.3390/jcdd9110378 · Cited by 13
Hsu, S.-J., Chao, Y., Lin, X., Liu, H., Zhang, Y., Hong, W.-F., Chen, M., Xu, X., Zhang, L., Ren, Z., et al. (2023) · Clinical & Experimental Immunology · doi:10.1093/cei/uxad036 · Cited by 12
Mitsuboshi, S., Hamano, H., Niimura, T., Ozaki, A. F., Patel, P. M., Lin, T., Tanaka, Y., Kimura, I., Iwata, N., Shiromizu, S., et al. (2023) · International Journal of Cancer · doi:10.1002/ijc.34616 · Cited by 12
Self-citationStimulatory and Inhibitory Co-signals in Autoimmunity
Okazaki, T., & Okazaki, I. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-981-32-9717-3_8 · Cited by 12
Self-citationBłyszczuk, P., Valaperti, A., & Eriksson, U. (2008) · Cardiovascular & Haematological Disorders - Drug Targets · doi:10.2174/1871529x10808040313 · Cited by 13
Alternatives to heart transplantation integration of biology with surgery
Chachques, J. C. (2010) · Frontiers in Bioscience-Elite · doi:10.2741/e276 · Cited by 12
Insight of immune checkpoint inhibitor related myocarditis
Pi, J.-K., Chen, X.-T., Zhang, Y., Chen, X.-M., Wang, Y.-C., Xu, J., Zhou, J.-H., Yu, S.-S., & Wu, S. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.113559 · Cited by 14
Li, J., Chen, L., Liu, X., Zhang, M., & Liu, X. (2025) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2025.09.006 · Cited by 12
Furusawa, S., Ikeda, M., Ide, T., Kanamura, T., Miyamoto, H. D., Abe, K., Ishimaru, K., Watanabe, M., Tsutsui, Y., Miyake, R., et al. (2023) · Circulation Heart Failure · doi:10.1161/circheartfailure.122.010347 · Cited by 11
Green, C., Chacon, J. A., Godinich, B. M., Hock, R. A., Kiesewetter, M., Raynor, M., Marwaha, K., Maharaj, S. S., & Holland, N. A. (2023) · Cancers · doi:10.3390/cancers15245707 · Cited by 14
Reyes‐Gibby, C. C., Qdaisat, A. Z., Ferrarotto, R., Fadol, A. P., Bischof, J. J., Coyne, C. J., Lipe, D. N., Hanna, E. Y., Shete, S. S., Abe, J., et al. (2023) · Head & Neck · doi:10.1002/hed.27604 · Cited by 11
Gao, H., Chen, Z., Yao, Y., He, Y., & Hu, X. (2024) · Frontiers in Oncology · doi:10.3389/fonc.2024.1453090 · Cited by 13
Myocarditis With Radiotherapy and Immunotherapy in Multiple Myeloma
Chang, A., Nasti, T. H., Khan, M. K., Parashar, S., Kaufman, J. L., Boise, L., Lonial, S., Ahmed, R., & Nooka, A. K. (2018) · Journal of Oncology Practice · doi:10.1200/jop.18.00208 · Cited by 11
Case Report: Cardiac Toxicity Associated With Immune Checkpoint Inhibitors
Chen, R., Peng, L., Qiu, Z., Wang, Y., Wei, F., Zhou, M., & Zhu, F. (2021) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.727445 · Cited by 13
Cardiac Troponin, Cognitive Function, and Dementia: A Systematic Review
Zonneveld, M. H., Abbel, D., le Cessie, S., Jukema, J. W., Noordam, R., & Trompet, S. (2022) · Aging and Disease · doi:10.14336/ad.2022.0818 · Cited by 12
Watson, R. A., Ye, W., Taylor, C. A., Jungkurth, E., Cooper, R. A., Tong, O., James, T., Shine, B. S. F., Hofer, M., Jenkins, D., et al. (2024) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2023-008151 · Cited by 11
Cheng, L. Z., Tang, X., Liu, L., Peng, J., Nishiura, K., Cheung, A. K. L., Guo, J., Wu, X., Tang, H. Y., An, M., et al. (2015) · mAbs · doi:10.1080/19420862.2015.1016695 · Cited by 11
Pembrolizumab-Induced Mobitz Type 2 Second-Degree Atrioventricular Block
Khan, A., Riaz, S., & Carhart, R. L. (2020) · Case Reports in Cardiology · doi:10.1155/2020/8428210 · Cited by 12
Cardiovascular Complications of Novel Anti-Cancer Immunotherapy: Old Problems from New Agents?
Chung, W., Youn, J., & Youn, H. (2020) · Korean Circulation Journal · doi:10.4070/kcj.2020.0158 · Cited by 13
Rubio‐Infante, N., Castillo, E. C., Alves‐Figueiredo, H., Ramos-González, M. R., Salazar‐Ramírez, F., Treviño, D. S., Soto‐Domínguez, A., Lozano, O., García‐Rivas, G., & Torre‐Amione, G. (2023) · ESC Heart Failure · doi:10.1002/ehf2.14614 · Cited by 10
Autoantibodies and Cardiomyopathy: Focus on Beta-1 Adrenergic Receptor Autoantibodies
Tang, W. H. W., & Prasad, S. V. N. (2022) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0000000000001264 · Cited by 11
Cellular Alterations in Immune Checkpoint Inhibitor Therapy-Related Cardiac Dysfunction
Michel, L., Ferdinandy, P., & Rassaf, T. (2024) · Current Heart Failure Reports · doi:10.1007/s11897-024-00652-2 · Cited by 11
Hurtado-de-Mendoza, D., Loaiza‐Bonilla, A., Bonilla-Reyes, P. A., & Alcorta, R. (2017) · Cureus · doi:10.7759/cureus.1258 · Cited by 10
Ribeiro, K. C., Campelo, R. P., Rodrigues, D. D. R. F., Mattos, E. C., Brandão, I. T., Silva, C. L., Bouskela, E., Martinez, C. G., & Kurtenbach, E. (2018) · Autoimmunity · doi:10.1080/08916934.2018.1514389 · Cited by 10
Li, X., Qu, L.-X., Ren, Y.-M., & Hu, C. J. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.707967 · Cited by 11
Synthesis and Immunomodulatory Activity of Fluorine‐Containing Bisphosphonates
Mizuta, S., Tagod, M. S. O., Iwasaki, M., Nakamura, Y., Senju, H., Mukae, H., Morita, C. T., & Tanaka, Y. (2019) · ChemMedChem · doi:10.1002/cmdc.201800764 · Cited by 10
Self-citationClinical Implications of Anti-cardiac Immunity in Dilated Cardiomyopathy
Caforio, A. L. P., Mahon, N., & McKenna, W. J. (2006) · Springer eBooks · doi:10.1007/3-540-30822-9_11 · Cited by 11
Halley, C. M., Lappé, J. M., Cotleur, A. C., Shrestha, K. L., Borowski, A. G., Pelfrey, C. M., Ransohoff, R. M., & Tang, W. H. W. (2011) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2011.01.003 · Cited by 10
Myocarditis and Dilated Cardiomyopathy
Rose, N. R., & Baughman, K. L. (2006) · Elsevier eBooks · doi:10.1016/b978-012595961-2/50066-4 · Cited by 10
Dilated cardiomyopathy (DCM) and myocarditis: Classification, clinical and autoimmune features
Caforio, A. L. P., Bottaro, S., & Iliceto, I. (2012) · Cited by 12
Autoantibodies Against Cardiac Troponin I: Friend or Foe?
Jahns, R. (2010) · European Journal of Heart Failure · doi:10.1093/eurjhf/hfq098 · Cited by 10
Dörr, M., Böhm, M., Erdmann, E., Groß, S., Mahabadi, A. A., Nauck, M., Nickenig, G., Schultheiß, H., Staudt, A., Werdan, K., et al. (2024) · European Journal of Heart Failure · doi:10.1002/ejhf.3476 · Cited by 9
Caught in the crossfire: cardiac complications of cancer therapy
Guerra, G., Mergiotti, M., Ardehali, H., Hirsch, E., & Ghigo, A. (2026) · Journal of Clinical Investigation · doi:10.1172/jci198289 · Cited by 9
Warrick, K. A., Johansen, A. K. Z., Jiao, M., Linnemann, M. E., Saha, I., Lin, S. J., Vallez, C. N., Hagan, T., Molkentin, J. D., & Pasare, C. (2026) · The Journal of Experimental Medicine · doi:10.1084/jem.20251717 · Cited by 10
Scard, C., Nguyen, J., Varey, É., Moustaghfir, I., Khammari, A., & Dréno, B. (2021) · European Journal of Dermatology · doi:10.1684/ejd.2021.4009 · Cited by 9
Immunomodulatory Treatment Strategies Targeting B Cells for Heart Failure
Zhang, X., Sun, Y., Wang, N., Zhang, Y., Xia, Y., & Liu, Y. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.854592 · Cited by 9
Bai, J., Wu, B., Zhao, S., Wang, G., Su, S., Lu, B., Hu, Y., Geng, Y., Guo, Z., Wan, J., et al. (2022) · Journal of Inflammation Research · doi:10.2147/jir.s384279 · Cited by 10
Abulizi, A., Yan, G.-P., Xu, Q., Muhetaer, R., Wu, S., Abudukelimu, K., Chen, X., Liu, C., & Li, J. (2024) · Scientific Reports · doi:10.1038/s41598-024-75099-5 · Cited by 9
New therapy to revert dysfunctional antibody responses during HIV-1 infection
Chiodi, F. (2010) · Journal of Clinical Investigation · doi:10.1172/jci44872 · Cited by 9
Chapoval, A. I., Chapoval, S. P., Shcherbakova, N. S., & Щербаков, Д. Н. (2019) · Russian Journal of Bioorganic Chemistry · doi:10.1134/s1068162019040101 · Cited by 9
Sun, Y. H., Hu, L., Peng, Y., Zhang, M., Wang, X., Xiao, H., Qiao, C., Wang, J., Luo, L., Feng, J., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.794226 · Cited by 10
Self-citationWang, R., Chen, Y., Xie, Y., Ma, X., & Liu, Y. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.111989 · Cited by 10
Staudt, Y., Trimpert, C., Birkenmeier, K., Krieg, T., Bemmann, T., Beug, D., Felix, S. B., & Staudt, A. (2006) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2006.01603.x · Cited by 9
Clinical Characteristics and Outcomes in Immune Checkpoint Inhibitor Therapy-Associated Myocarditis
Thakker, R. A., Lee, M. A., Albaeni, A., Elbadawi, A., Suthar, K. H., Perez, C., Sonstein, L. K., Farr, N. M., Venkatesan, R., Khalife, W. I., et al. (2021) · Cardiology Research · doi:10.14740/cr1319 · Cited by 10
An integrative review of nonobvious puzzles of cellular and molecular cardiooncology
Uruski, P., Matuszewska, J., Leśniewska, A., Rychlewski, D., Niklas, A. A., Mikuła‐Pietrasik, J., Tykarski, A., & Książek, K. (2023) · Cellular & Molecular Biology Letters · doi:10.1186/s11658-023-00451-y · Cited by 9
Soroureddin, Z., Nouri‐Vaskeh, M., Maleki, M., Baghbanzadeh, A., Hajiasgharzadeh, K., Sadeghi, M. T., & Baradaran, B. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.117720 · Cited by 10
PD-L1 and PD-1 in immune regulation and their implications in blood cancers
Aghbash, P. S., Mehdizadeh, F., Pourbeiragh, G., Yazdani, Y., Baghi, H. B., Jafari-Sales, A., Pashazadeh, M., & Kangari, P. (2024) · Advances in Cancer Biology - Metastasis · doi:10.1016/j.adcanc.2024.100125 · Cited by 11
Factors associated with immune‑related severe adverse events (Review)
Su, Z., Guan, M., Zhang, L., & Lian, X. (2024) · Molecular and Clinical Oncology · doi:10.3892/mco.2024.2798 · Cited by 8
van der Vegt, S. A., Wang, Y., Polonchuk, L., Wang, K., Waters, S. L., & Baker, R. E. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.966180 · Cited by 9
MacCord, K. (2024) · University of Chicago Press eBooks · doi:10.7208/chicago/9780226830506.001.0001 · Cited by 8
Boldizsár, F., Tarjányi, O., Olasz, K., Hegyi, A., Mikecz, K., Glant, T. T., & Rauch, T. A. (2016) · Cardiovascular Pathology · doi:10.1016/j.carpath.2016.05.003 · Cited by 10
Kono, D. H., & Theofilopoulos, A. N. (2011) · Elsevier eBooks · doi:10.1016/b978-0-12-374994-9.10004-x · Cited by 8
Kurzhals, J. K., Graf, T., Boch, K., Grzyska, U., Frydrychowicz, A. P., Zillikens, D., Terheyden, P. A. M., & Langan, E. A. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.691618 · Cited by 8
Bradyarrhythmias in Cardio-Oncology
Fonseca, M., Cheng, E., Do, D. H., Haldar, S., Kutty, S., Yang, E. H., Ghosh, A. K., & Guha, A. (2021) · South Asian Journal of Cancer · doi:10.1055/s-0041-1731907 · Cited by 8
Autoantibodies against cardiac troponin I in patients presenting with myocarditis
Matsumori, A., Shimada, T., Hattori, H., Shimada, M., & Mason, J. W. (2011) · Global Heart · doi:10.1016/j.cvdpc.2011.02.004 · Cited by 8
Self-citationCardiotoxicity danger in immunotherapy
Jagielska, B., Ozdowska, P., Gepner, K., Kubala, S., SIEDLECKI, J. A., Sarnowski, T. J., & Sarnowska, E. A. (2020) · IUBMB Life · doi:10.1002/iub.2299 · Cited by 9
Mechanismen der Kardiotoxizität onkologischer Therapien
Lehmann, L., & Fröhling, S. (2020) · Der Internist · doi:10.1007/s00108-020-00881-2 · Cited by 8
Changes in tumor and cardiac metabolism upon immune checkpoint
Leven, A., Wagner, N., Nienaber, S., Messiha, D., Tasdogan, A., & Ugurel, S. (2024) · Basic Research in Cardiology · doi:10.1007/s00395-024-01092-8 · Cited by 8
Cao, H., Dai, H., Li, S., Afzal, Z., Wang, X., Wen, Z., Xiao, K., Zhao, Y., Li, J., & Yang, B. (2025) · Scientific Reports · doi:10.1038/s41598-025-05635-4 · Cited by 10
Bian, J., Niu, Y., Ma, Y., Chen, F., & Ma, N. (2022) · Applied Bionics and Biomechanics · doi:10.1155/2022/8537966 · Cited by 8
RetractedShao, Y., Yang, W. Y., Nanayakkara, G., Saaoud, F., Issa, M. B., Xu, K., Lu, Y., Jiang, X., Mohsin, S., Wang, H., et al. (2024) · International Journal of Drug Discovery and Pharmacology · doi:10.53941/ijddp.2024.100022 · Cited by 12
Wu, Y., Zhou, Y., Xia, S., & Meng, Z. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1605958 · Cited by 7
Troponin and Anti-Troponin Autoantibody Levels in Patients with Ventricular Noncompaction
Erer, H. B., Güvenç, T. S., Kemık, A. S., Yılmaz, H. Y., Kul, Ş., Altay, S., Sayar, N., Kaya, Y., & Eren, M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0057648 · Cited by 7
An in vivo method for diversifying the functions of therapeutic antibodies
Tian, M., Cheng, H.-L., Kimble, M. T., McGovern, K., Waddicor, P., Chen, Y., Cantor, E., Qiu, M., Tuchel, M.-E., Dao, M. N., et al. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2025596118 · Cited by 8
Metadata
- Authors
- Okazaki, T., Tanaka, Y., Nishio, R., Mitsuiye, T., Mizoguchi, A., Wang, J., Ishida, M., Hiai, H., Matsumori, A., Minato, N., & Honjo, T.
- Affiliations
- Kyoto University (JP)
- Mie University (JP)
- Corresponding author
- Honjo, Tasuku
- ORCID
- Venue
- Nature Medicine
- Published
- 2003-11-02
- Volume
- 9
- Issue
- 12
- Pages
- 1477-1483
- ISSN
- 1078-8956 (ISSN-L)
- 1546-170X
- OpenAlex
- W2140419562
- Semantic Scholar
- 8b8bf12ad1a303d244e325c58410b356c4ed2945
- Cited by
- 689
- References
- 38
- Citations by year
- 2026: 24 · 2025: 30 · 2024: 44 · 2023: 36 · 2022: 49 · 2021: 49 · 2020: 47 · 2019: 46 · 2018: 28 · 2017: 30 · 2016: 32 · 2015: 19 · 2014: 20 · 2013: 22 · 2012: 16
- FWCI
- 16.31
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Viral Infections and Immunology Research
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiomyopathy and Myosin Studies
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac electrophysiology and arrhythmias
- Keywords
- cardiac troponin I, autoantibodies, dilated cardiomyopathy, PD-1 deficiency, autoimmune cardiomyopathy, familial hypertrophic cardiomyopathy, L-type calcium current, cardiac dysfunction, monoclonal antibodies
- MeSH terms
- Animals, Antibodies, Monoclonal, Antigens, Surface, Autoantibodies, Base Sequence, Cardiomyopathy, Dilated, Humans, Mice, Inbred A, Mice, Inbred BALB C, Mice, Nude, Antigens, CD, Rats, Wistar, DNA, Complementary, Mice, Knockout, Troponin I, Calcium Signaling, Myocytes, Cardiac, Apoptosis Regulatory Proteins, Mice, Rats, Programmed Cell Death 1 Receptor
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.